Experience in nucleic acid amplification testing (NAT) for hepatitis C (HCV) in Canada

被引：0
|
作者：
Sher, GD [1 ]
Zuber, ED [1 ]
Scalia, V [1 ]
机构：
[1] Canadian Blood Serv, Ottawa, ON, Canada
来源：
TRANSFUSION | 2000年 / 40卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：89S / 89S
页数：1
相关论文
共 50 条
  • [31] Ambiguous Nucleic Acid Tests (NAT) Results - Case of a Donor with Intermittent HCV NAT(+) but No HCV Transmission
    Nowicki, M.
    Prince, H.
    Chinchilla, C.
    De Los Santos, C.
    Trageser, J.
    Stocks, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 511 - 511
  • [32] Nucleic acid testing (NAT) for HCV RNA in Italian transfusion centres: An external quality assessment
    Candido, Angela
    Chionne, Paola
    Milazzo, Luisa
    Dettori, Stefano
    Madonna, Elisabetta
    Taffon, Stefania
    Kondili, Loreta A.
    Barca, Alessandra
    Hassan, Hamisa J.
    Rapicetta, Maria
    JOURNAL OF CLINICAL VIROLOGY, 2008, 41 (04) : 277 - 282
  • [33] Nucleic acid-amplification testing for hepatitis B in cornea donors
    Maria Gema Fornés
    Maria Angustias Jiménez
    Marcela Eisman
    Jose Luis Gómez Villagrán
    Rafael Villalba
    Cell and Tissue Banking, 2016, 17 : 341 - 344
  • [34] Nucleic acid-amplification testing for hepatitis B in cornea donors
    Gema Fornes, Maria
    Angustias Jimenez, Maria
    Eisman, Marcela
    Gomez Villagran, Jose Luis
    Villalba, Rafael
    CELL AND TISSUE BANKING, 2016, 17 (02) : 341 - 344
  • [35] Nucleic acid testing: the international status of NAT
    van der Poel, CL
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2001, 8 (03) : 240 - 241
  • [36] Acute hepatitis C virus seroconversion in a Scottish blood donor: HCV antigen is not comparable with HCV nucleic acid amplification technology screening
    Dow, BC
    Munro, H
    Buchanan, I
    Ferguson, K
    Davidson, F
    Lycett, C
    Jarvis, M
    Cleland, A
    Petrik, J
    Lumley, S
    Maclean, A
    VOX SANGUINIS, 2004, 86 (01) : 15 - 20
  • [37] Evaluation of Nucleic Acid Testing (NAT) and Serology for Hepatitis B Virus in a Donor Population
    Winkelman, V.
    Cyrus, S.
    Spizman, R.
    Williamson, P. C.
    TRANSFUSION, 2013, 53 : 28A - 28A
  • [38] Comparison of Outcomes of Hepatitis C Virus (hcv) Nucleic Acid (nat) Positive Donor Between Hcv-naiVe and Hcv plus Recpients - A Donor Mate Analysis
    Kamal, J.
    Sharma, B.
    Doyle, A.
    Kumar, A.
    Nishio-Lucar, A.
    Rao, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 335 - 336
  • [39] Brazilian Nucleic Acid Amplification Testing (NAT) versus Transfusion Safety: Where Are We Actually?
    Araujo, P.
    Latini, F.
    Dodd, R. Y.
    Diaz, R. S.
    Girao, M. J.
    TRANSFUSION, 2014, 54 : 27A - 27A
  • [40] Epidemiology of blood donors in Japan, positive for hepatitis B virus and hepatitis C virus by nucleic acid amplification testing
    Murokawa, H
    Yoshikawa, A
    Ohnuma, H
    Iwata, A
    Katoh, N
    Miyamoto, M
    Mine, H
    Emura, H
    Tadokoro, K
    VOX SANGUINIS, 2005, 88 (01) : 10 - 16
12345